Defense Health Agency SBIRSTTR Programs Enabling Biomedical and
Defense Health Agency SBIR/STTR Programs: Enabling Biomedical and Healthcare Solutions CAPT Joseph Cohn, Ph. D DHA J-9 Chief, Research Program Administration Division Program Manager, DHA SBIR, STTR, and Rapid Innovation Fund Programs “Medically Ready Force…Ready Medical Force”
Agency Introduction: DHA § The Defense Health Agency (DHA) is a joint, integrated Combat Support Agency that enables the Army, Navy, and Air Force medical services to provide a medically ready force and ready medical force to Combatant Commands in both peacetime and wartime. § The DHA SBIR and STTR Programs regularly provide Phase I and Phase II funding opportunities. Direct to Phase II, Phase II Enhancement and Sequential Phase II mechanisms are also utilized on a limited basis. § DHA SBIR/STTR does not participate in TABA at this time. § In-house transition assistance through a Technical Assistance Advocate begins at the awarding of a Phase I contract. Adopted contracts receive transition assistance. No Phase 0 Program is supported. “Medically Ready Force…Ready Medical Force” 1
The Future Operational Environment Build a lethal Joint Force that possesses decisive advantages for any conflict Enhance Nation’s security by ensuring Warfighters are ready to conduct full range of operations Operate in environments that are highly distributed with minimal organic health service infrastructure How do we prepare our medical force to ensure a medically ready force? “Medically Ready Force…Ready Medical Force” 2
Meeting the Future Through Biomedical Research and Development Future Battlespace … …Demands Advanced Solutions Increased /Time Distance Advanced Trauma Care Training Distributed Operations Degraded / Denied Comms R&D Injury Detection and Diagnostics Injury Treatment / Prolonged Field Care Patient Transport / En Route Logistics Challenges Care Challenged Air Superiority Rehabilitation How do we ensure we enable these solutions? “Medically Ready Force…Ready Medical Force”
Biomedical R&D Investment Approach Primarily targeted in areas, or environments, that are militarily unique for which there are limited or no commercial partners or interests § The Do. D leads in key biomedical research areas: e. g. prolonged field care, en route care, forward surgical/intensive critical care, hemorrhage control and blood products § The Do. D leverages in areas where commercial technologies exist and can be tailored for military use: e. g. medical simulation and training, diagnostic systems, pain management, infectious diseases § The Do. D watches areas of emerging interest: e. g. Medical Radiological Defense and other tech areas like Artificial Intelligence How can we apply this approach? “Medically Ready Force…Ready Medical Force” 4
Summary of Major Investments Defense Health Program Military Infectious Diseases (JPC-2) Medical Simulation & Information Sciences (JPC-1) • • • Theater/Operational Medicine • Medical Resourcing • Information Technology Infrastructure and Data Management Combat Casualty Care (JPC-6) • Injury Prevention and Reduction • Psychological Health and Resilience • Physiological Health • Environmental Health and Protection • Wearable Sensors Bacterial Parasitic Viral Information & Devices Radiation Health Effects (JPC-7) • Post-exposure mitigation of radiation injury • Protection and prevention • Mechanism of radiation injury • Development of biodosimetry tools • • Military Operational Medicine (JPC-5) Clinical & Rehabilitative Medicine (JPC-8) Neurotrauma & Traumatic Brain Injury Hemorrhage Control & Resuscitation Forward Surgical- EN Route Care Photonics & Light-Based Innovation for Severe Injury “Medically Ready Force…Ready Medical Force” • Regenerative Medicine • Neuromusculoskeletal Injury Rehabilitation • Pain Management • Sensory System Injury Photos courtesy of Do. D
DHA SBIR/STTR Timeline Topics Phase III Do. D BAA SBIR CY. 1, CY. 2, and CY. 3 STTR CY. A, CY. B, and CY. C Feasibility Study 6 Months Prototype Development 2 Years PH II Enhancement 1: 1 matching funds up to $750, 000 DRAFT Pre Decisional Commercialization Federal Government or Private Industry $ No SBIR Funds “Medically Ready Force…Ready Medical Force” 6
Contact Information General Agency Information: Defense Health Agency, Falls Church, VA https: //health. mil/About-MHS/OASDHA/Defense-Health-Agency Do. D SBIR/STTR Broad Agency Announcements: https: //www. dodsbirsttr. mil/submissions/login Contact the DHA SBIR/STTR Programs: CAPT Joseph Cohn Chief, Research Program Administration Division Program Manager, DHA SBIR, STTR, and Rapid Innovation Fund Programs DHA_SBIR-STTR@mail. mil 7
- Slides: 8